Leiv Lea

Leiv Lea

Chief Financial OfficeratCorvus Pharmaceuticals· In proxies 2022–2025

Pay in FY2025+99% from the year before · Corvus Pharmaceuticals stock +43.9% the same year

Leiv Lea was paid $3.2M in FY2025 (Dec), up 99%. Corvus Pharmaceuticals stock rose 43.9% that year.

Pay$100 in the stock at the end of FY21 → $320
Pay is from the Summary Compensation Table of each Corvus Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Corvus PharmaceuticalsPublic company · 4 yr
    • Chief Financial Officer2022 – Present · 4 yrStock in role +316%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?